Symanowski, James
95  results:
Search for persons X
?
3

CHARACTERISTICS, TREATMENTS, AND OUTCOMES OF PATIENTS WITH ..:

Karsh, Lawrence ; Symanowski, James ; Shore, Neal...
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  - p. S16-S17 , 2024
 
?
4

P-227 Safety and clinical activity of ruxolitinib combined ..:

Atrash, Shebli ; Symanowski, James ; Norek, Sarah...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S160 , 2023
 
?
6

P-226 Safety and clinical activity of belantamab mafodotin ..:

Atrash, Shebli ; Symanowski, James ; Paul, Barry...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S159-S160 , 2023
 
?
8

Identification of potential biomarkers and novel therapeuti..:

Burgess, Earle F. ; Sanders, J. Alexa ; Livasy, Chad...
Urologic Oncology: Seminars and Original Investigations.  40 (2022)  8 - p. 383.e1-383.e10 , 2022
 
?
12

553. Critically Ill patients Receiving Tocilizumab Compared..:

Leonard, Michael ; Asher, anthony ; Kooken, Banks...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S342-S342 , 2020
 
?
13

Discordance of high PD-L1 expression in primary and metasta..:

Burgess, Earle F. ; Livasy, Chad ; Hartman, Aaron...
Urologic Oncology: Seminars and Original Investigations.  37 (2019)  5 - p. 299.e19-299.e25 , 2019
 
?
14

Evaluation of CYP2C19 Genotype‐Guided Voriconazole Prophyla..:

Patel, Jai N. ; Hamadeh, Issam S. ; Robinson, Myra...
Clinical Pharmacology & Therapeutics.  107 (2019)  3 - p. 571-579 , 2019
 
?
15

High aurora kinase expression identifies patients with musc..:

Burgess, Earle F. ; Livasy, Chad ; Trufan, Sally...
Urologic Oncology: Seminars and Original Investigations.  37 (2019)  12 - p. 900-906 , 2019
 
1-15